Φορτώνει......
Indeterminate Findings on Oncologic PET/CT: What Difference Does PET/MRI Make?
BACKGROUND: Positron emission tomography/computed tomography (PET/CT) with 2-deoxy-2-[(18)F]fluoro-D-glucose (FDG) has become the standard of care for the initial staging and subsequent treatment response assessment of many different malignancies. Despite this success, PET/CT is often supplemented b...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Nucl Med Mol Imaging |
|---|---|
| Κύριοι συγγραφείς: | , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Springer Berlin Heidelberg
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5135691/ https://ncbi.nlm.nih.gov/pubmed/27994684 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13139-016-0405-1 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|